Evaluation of S-[ 11C]citalopram as a radioligand for in vivo labelling of 5-hydroxytryptamine uptake sites

The biologically active S-enantiomer of [ N-methyl- 11C]citalopram was evaluated as a radioligand for in vivo labelling of the 5-hydroxytryptamine uptake site in brain, using ex vivo tissue counting in rats and positron emission tomography in man. In rats, the maximal signal for total versus non-spe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology Nuclear medicine and biology, 1992-11, Vol.19 (8), p.851-855
Hauptverfasser: Hume, S.P., Lammertsma, A.A., Bench, C.J., Pike, V.W., Pascali, C., Cremer, J.E., Dolan, R.J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The biologically active S-enantiomer of [ N-methyl- 11C]citalopram was evaluated as a radioligand for in vivo labelling of the 5-hydroxytryptamine uptake site in brain, using ex vivo tissue counting in rats and positron emission tomography in man. In rats, the maximal signal for total versus non-specific binding was approx. 2 at 60–120 min after radioligand injection. Subsequent studies in man failed to identify a specific signal over a 90 min scanning period, due to prolonged retention of non-specific label.
ISSN:0883-2897
DOI:10.1016/0883-2897(92)90171-T